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Background: Glucose intolerance is a major health problem and is associated with increased risk of progression to
type 2 diabetes mellitus and cardiovascular disease. However, whether glucose intolerance is related to impaired
myocardial perfusion is not known. The purpose of the present study was to study the effect of diet-induced
glucose intolerance on myocardial function and perfusion during baseline and pharmacological
induced hyperaemia.
Methods: Male Wistar rats were randomly exposed to a high fat diet (HFD) or control diet (CD) (n = 8 per group).
After 4 weeks, rats underwent an oral glucose tolerance test. Subsequently, rats underwent (contrast)
echocardiography to determine myocardial function and perfusion during baseline and dipyridamole-induced
hyperaemia (20 mg/kg for 10 min).
Results: Four weeks of HFD feeding resulted in glucose intolerance compared to CD-feeding. Contractile function
as represented by fractional shortening was not altered in HFD-fed rats compared to CD-fed rats under baseline
conditions. However, dipyridamole increased fractional shortening in CD-fed rats, but not in HFD-fed rats. Basal
myocardial perfusion, as measured by estimate of perfusion, was similar in CD- and HFD-fed rats, whereas
dipyridamole increased estimate of perfusion in CD-fed rats, but not in HFD-fed rats. However, flow reserve was not
different between CD- and HFD-fed rats.
Conclusions: Diet-induced glucose intolerance is associated with impaired myocardial function during conditions
of hyperaemia, but myocardial perfusion is maintained. These findings may result in new insights into the effect of
glucose intolerance on myocardial function and perfusion during hyperaemia.
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Glucose intolerance defines the intermittent stage between
transition from normal glucose levels to type 2 diabetes
mellitus [1]. Glucose intolerance is a predictor of cardio-
vascular disease [2,3] and known to associate with vascular
dysfunction and consequent impairment of organ perfu-
sion as one of the appearing consequences [4]. Myocardial
perfusion in combination with myocardial performance* Correspondence: c.vandenbrom@vumc.nl
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distribution, and reproduction in any mediumplays a central role in the balance between myocardial
energy supply and demand. Under physiological condi-
tions, myocardial blood flow and function are in bal-
ance [5], while pathophysiological conditions leading to
vascular dysfunction, such as glucose intolerance, could
alter balance between energy supply and demand. Al-
though glucose intolerance-induced vascular dysfunc-
tion may impair organ perfusion, data elucidating the
effects of glucose intolerance on the perfusion of vital
organs like the heart are limited. Up to now, only one
group showed that insulin resistance in prediabetic
patients was associated with myocardial perfusion
defects [6,7].Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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for assessment and quantification of myocardial perfu-
sion that is clinically applied for specific indications in
the cardiology setting. Using this technique it has been
shown that myocardial blood flow reserve, as a measure
for vascular function, is reduced in type 1 diabetic rats
[8] and type 1 diabetic patients [9] when compared to
normoglycaemic controls. There are currently limited
data available on myocardial perfusion in glucose in-
tolerance. In the present study we therefore studied
myocardial function and perfusion under baseline and
pharmacological-induced hyperaemic conditions in a rat
model for diet-induced glucose intolerance using con-
trast echocardiography. Our hypothesis is that glucose
intolerance reduces the myocardial vasodilating capacity,
which blunts the increase in myocardial perfusion dur-
ing hyperaemia. This study demonstrates that diet-
induced glucose intolerance is associated with impaired
myocardial function during conditions of hyperaemia,
but not myocardial perfusion.Methods
Animals and experimental set-up
All experiments were approved by the Institutional Ani-
mal Care and Use Committee of the VU University, and
were conducted following the European Convention for
the Protection of Vertebrate Animals used for Experi-
mental and Other Scientific Purposes [10]. The per-
formed research is in compliance with the modern
ARRIVE guidelines on animal research [11].
Adult male Wistar rats (n = 16; body weight 262 ± 1 g;
Harlan CBP, Horst, the Netherlands) were fed a high fat
diet (HFD) for a period of 4 weeks (n = 8). Animals that
received a diet low in fat and sugars (control diet; CD)
for 4 weeks served as controls (n = 8). Animals were
housed in a temperature-controlled room (20-23 °C; 40-
60% humidity) under a 12/12 h light/dark cycle starting
at 6.00 am. After 4 weeks, rats underwent an oral glu-
cose tolerance test and (contrast) echocardiography dur-
ing baseline and after dipyridamole infusion.Baseline
Anaesthesia Echo
4 weeks CD 10 min 5 min
4 weeks HFD 10 min 5 min
Contras
echo
Figure 1 Protocol (contrast) echocardiography. After 4 weeks of contro
cannulation of the jugular vein followed by echocardiography (echo) and c
dipyridamole-induced hyperaemia.Diets
High fat diet was obtained from Research Diets
(D12451, New Brunswick, NJ). The HFD consisted of
24 wt% protein, 24 wt% fat and 41 wt% carbohydrates
(8.5 wt% starch, 20.1 wt% sucrose). Control diet
(Teklad 2016) was obtained from Harlan (Horst, The
Netherlands) and consisted of 17 wt% protein, 4 wt%
fat and 61 wt% carbohydrates (45.1 wt% starch,
5.0 wt% sucrose).
Oral glucose tolerance test
Rats fasted overnight received an oral glucose load
(2 g/kg of body weight). Blood glucose levels were mea-
sured from tail bleeds with a Precision Xceed Blood Glu-
cose monitoring system (MediSense, UK) before (0) and
15, 30, 60, 90 and 120 min after glucose ingestion [12].
At similar time points, plasma insulin (LINCO research,
St. Charles, Missouri) levels were measured as described
previously [12].
Plasma measurements
Plasma haematocrit levels were determined using micro-
centrifugation. Plasma free fatty acids (WAKO NEFA-C,
Wako Pure Chemical Industries, Osaka, Japan), plasma
high-density lipoprotein (HDL) cholesterol and plasma
low-density lipoprotein (LDL)/very-low-density lipopro-
tein (VLDL) cholesterol (Abcam, Cambridge, MA) were
measured after overnight fasting as previously described
[13,14].
Cannulation of the jugular vein
For infusion of the contrast agent for echocardiography,
a catheter was placed in the jugular vein under S-Ketamine
(KetanestW, 150 mg/kg, Pfizer, the Netherlands) and
Diazepam (3 mg/kg, Centrafarm, the Netherlands)
anaesthesia intraperitoneally. After surgery, echocardi-
ography and contrast echocardiography to determine
myocardial function and perfusion, respectively, were
performed during baseline and dipyridamole-induced
hyperaemia (20 mg/kg for 10 minutes) (Figure 1).Hyperaemia
Sacrifice
10 min 5 min 5 min5 min
10 min 5 min 5 min5 min
t Contrast
echo
EchoDipyridamole
infusion
l diet (CD) or high fat diet (HFD) feeding, rats received anaesthesia for
ontract echocardiography (contrast echo) during baseline and
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Echocardiography (Siemens, ACUSON, Sequoia 512)
was performed as previously described [14]. Briefly, wall
thickness (WT) and LV-dimensions (D) during end-
systole (ES) and end-diastole (ED) were determined in
the M- (motion) mode of the parasternal short-axis view
at the level of the papillary muscles. Left ventricular con-
tractile function was calculated by the fractional shorten-
ing = (EDD-ESD)/EDD 100%. Analyses were performed
off-line (Image-Arena 2.9.1, TomTec Imaging Systems,
Unterschleissheim/Munich, Germany). All parameters
were averaged over at least three cardiac contractile
cycles.Myocardial contrast echocardiography
Contrast echocardiography was performed using a Sie-
mens (ACUSON, Sequoia 512) equipped with a 14 MHz
linear array transducer (Philips Healthcare, Best, The
Netherlands). The contrast agent SonovueW (Bracco Im-
aging, Italy), which contains 2x108-5x108/ml sulphur
hexafluoride-filled, phospholipid-coated microbubbles
with a diameter of 1–10 μm, was prepared according the
manufacturer’s instructions and diluted twice by adding
5 ml NaCl (0.9%). Microbubbles were continuously
infused into the jugular vein with a rate of 600 μl/min
using a dedicated syringe pump (Vueject, Bracco SA,
Switzerland). After two minutes of microbubble infusion,
perfusion images were taken of the short axis view of
the left ventricle at the level of the papillary muscles.B
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Figure 2 Typical example of contrast echocardiography with replenisLow acoustic power (mechanical index [MI] 0.20 max)
was used for microbubble detection. A perfusion se-
quence consisted of about 10 cardiac cycles of low MI
imaging, followed by a burst of high acoustic power
(MI 1.8) for complete contrast destruction. Subse-
quently, on average 20 cardiac cycles of low MI images
were acquired at a frame rate of 14 Hz to allow contrast
replenishment in the myocardium. All data were stored
for offline analysis.Myocardial contrast echocardiography analysis
Custom-designed software was used for analysis of the
estimate of perfusion (Matlab, 7.10, R2010A, Math-
Works Inc. Massachusetts, USA) with special thanks to
R. Meijer. For each cardiac cycle the end-systolic frame
was selected manually and regions of interest were
drawn in the posterior wall in the short axis view of the
left ventricle. Myocardial signal intensity extracted from
the frames before microbubble destruction were used to
calculate myocardial plateau intensity A. Myocardial sig-
nal intensities from the frames after microbubble de-
struction were corrected for background noise by
subtracting the signal intensity of the first frame after
microbubble destruction (Y0). These intensities were
then fitted (Y =Y0 + (A-Y0)*(1-exp
(−ß *x))) for calculation
of ß, which was transformed into min-1 for further ana-
lysis (Figure 2). The estimate of perfusion was calculated
as A * ß. The flow reserve was calculated as the ratio of
hyperaemic and baseline estimate of perfusion.C
1.5 2.0
Baseline
Hyperaemia
C
hment curve in rats.
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All data are presented as mean ± SEM. Between group
comparisons (CD vs. HFD) were performed using a stu-
dent t-test, whereas baseline vs. dipyridamole interven-
tion was tested with a paired student t-test. Oral glucose
tolerance test was tested with one-way ANOVA with
repeated measurements and Bonferroni post-hoc test. p
< 0.05 was considered as statistically significant.
Results
Short-term high fat diet feeding results in mild glucose
intolerance
Characteristics of rats after the diet intervention are
summarised in Table 1. HFD feeding did not affect body
weight, but increased perirenal and epidydimal fat
weight. No changes were found in heart weight and tibia
length between groups. Haematocrit, blood glucose,
plasma insulin, free fatty acid and LDL/VLDL choles-
terol levels were unaltered, whereas plasma HDL choles-
terol levels were significantly decreased compared to
controls. Post-load blood glucose levels were increased
in HFD-fed rats compared to CD-fed rats, whereas post-
load plasma insulin levels remained unchanged after
HFD and CD feeding (Figure 3), indicating mild glucose
intolerance.
High fat diet feeding impaired contractile function during
dipyridamole-induced hyperaemia
Table 2 shows a summary of the echocardiographic
parameters measured after 4 weeks of HFD feeding dur-
ing baseline and dipyridamole-induced hyperaemia. HFD
feeding resulted in decreased lumen diameter during
end diastole at baseline and reduced systolic wallTable 1 Characteristics after short-term diet intervention
CD HFD
Body composition
Body weight (g) 400 ± 6 408 ± 3
Perirenal fat (g) 6.3 ± 0.5 7.5 ± 0.4
Epidydimal fat (g) 7.4 ± 0.4 9.4 ± 0.5 *
Heart weight (g) 1.22 ± 0.05 1.31 ± 0.06
Tibia length (cm) 3.97 ± 0.05 3.89 ± 0.05
Blood/plasma characteristics
Hematocrit (%) 45.2 ± 0.7 44.8 ± 0.7
Blood glucose (mmol/L) 4.4 ± 0.2 4.5 ± 0.2
Plasma insulin (pmol/L) 95.2 ± 14.1 130.8 ± 29.1
Plasma free fatty acid levels (mmol/L) 1.22 ± 0.07 1.09 ± 0.07
Plasma HDL cholesterol (mg/dL) 318.7 ± 13.8 242.6 ± 15.4 *
Plasma LDL/VLDL cholesterol (mg/dL) 7.73 ± 1.23 .45 ± 0.53
Data are mean ± SEM, n = 8, student t-test, * p< 0.05 vs. CD. CD, control diet;
HFD, high fat diet.thickness after dipyridamole infusion. Dipyridamole in-
fusion increased systolic and diastolic wall thickness in
CD-fed rats, whereas in HFD-fed rats the end diastolic
lumen diameter was increased.
Contractile function, as represented by fractional
shortening, was unaffected by HFD feeding under base-
line conditions (Figure 4). During dipyridamole infusion,
fractional shortening was increased in CD-fed rats, but
not in HFD-fed rats, whereas fractional shortening was
even decreased in HFD vs. CD-fed rats, suggesting
impaired contractile function during dipyridamole-
induced hyperaemia.
Unchanged myocardial perfusion after high fat diet
feeding
HFD-feeding did not alter plateau intensity A, β
and estimate of perfusion compared to CD-fed rats
(Figure 5A-C). Dipyridamole infusion increased plateau
intensity A, β and estimate of perfusion in CD-fed rats
(Figure 5A-C), however, failed to reach significance. In
HFD-fed rats, only β was significantly increased after di-
pyridamole infusion (Figure 5A-C). No differences were
found in flow reserve between CD- and HFD-fed rats
(Figure 5D), suggesting unaltered myocardial perfusion
after 4 weeks of HFD feeding.
Discussion
In the present study, we examined the effect of glucose
intolerance on myocardial function and perfusion. We
found that short-term high fat diet feeding resulted
in glucose intolerance without affecting myocardial
function and perfusion under baseline conditions.
Diet-induced glucose intolerance impaired myocardial
contractile function during conditions of hyperaemia,
in the absence of alterations in myocardial perfusion.
The present study showed that short-term high fat diet
feeding resulted in glucose intolerance without obesity
affecting myocardial contractile function under resting
conditions. Our results confirm previous findings, show-
ing that 4 weeks of high fat diet feeding in rats resulted
in glucose intolerance without affecting function [15],
whereas 8 weeks of high fat diet feeding resulted in glu-
cose intolerance with mildly impaired contractile func-
tion [15]. One of the suggested mechanisms that may
contribute to alterations in myocardial blood flow during
prediabetes or diabetes are changes in nitric oxide avail-
ability. High fat diet feeding in male rats decreased nitric
oxide availability [16], whereas increased nitric oxide
bioavailability in eNOS−/− mice has been shown to at-
tenuate high fat diet-induced metabolic alterations asso-
ciated with insulin resistance [17]. Taken together, these
results suggest that 4 weeks of high fat diet feeding in a
rat results in a mild model of glucose intolerance with-
out impaired myocardial function.
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Figure 3 HFD induced mild glucose intolerance. Blood glucose (A,B) and plasma insulin levels (C,D) following an oral glucose load in rats fed
a control diet (CD) or high fat diet (HFD). Data are expressed as mean± SEM, n = 7-8. One-way ANOVA with repeated measurements and
Bonferroni post-hoc test (A,C) or student t-test (B,D), * p< 0.05 vs. CD.
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http://www.cardiab.com/content/11/1/74Under physiological conditions, myocardial perfusion
and function are in balance [5]. However, a perfusion-
contraction mismatch might exist in glucose intolerance.
In the present study, diet-induced glucose intolerance
did not affect myocardial perfusion measured with con-
trast echocardiography during baseline conditions.
These results are in agreement with Menard et al. [18],
who found no differences in myocardial perfusion index
measured by [13N] ammonia PET in rats fed a high fruc-
tose and high fat diet with additional streptozotocin. Ac-
cordingly, in patients with insulin resistance or glucose
tolerance it was found that insulin resistance was asso-
ciated with a defect in myocardial perfusion measured
by single photon emission computed tomography, which
was independent of glucose tolerance and obesity [6].Table 2 Echocardiographic parameters after short-term diet i
CD
Baseline Hy
ED lumen diameter (mm) 7.40 ± 0.20 7.4
ES lumen diameter (mm) 3.18 ± 0.21 2.5
Diastolic WT (mm) 1.30 ± 0.05 1.4
Systolic WT (mm) 2.96 ± 0.15 3.4
Data are mean ± SEM, n = 8, student t-test, * p< 0.05 diet effect, # p< 0.05 hyperaem
WT, wall thickness.Together, these results suggest that under baseline con-
ditions diet-induced glucose intolerance does not affect
myocardial function and perfusion.
Dipyridamole is used to pharmacologically induce max-
imal vasodilation. Dipyridamole blocks the uptake of ad-
enosine, thereby increasing the circulating levels of
adenosine, which results in maximal coronary blood flow
due to decreased coronary vascular resistance [19]. During
hyperaemia, myocardial contractile function was increased
in healthy rats, but not in rats with diet-induced glucose
intolerance. On the contrary, this hyperaemic-induced in-
crease in contractile function was not seen in healthy and
type 1 diabetic rats [8]. Besides glucose intolerance, several
variables could be associated with alterations in myocar-
dial function. Our experimental rat model with high fatntervention
HFD
peraemia Baseline Hyperaemia
6 ± 0.14 6.50 ± 0.25 * 7.07 ± 0.30 #
8 ± 0.20 2.99 ± 0.28 2.89 ± 0.19
1 ± 0.06 # 1.34 ± 0.09 1.42 ± 0.04
0 ± 0.06 # 2.85 ± 0.134 3.10 ± 0.10 *
ia effect. CD, control diet; HFD, high fat diet; ED, end-diastolic; ES, end-systolic;
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Figure 4 Contractile function during baseline and dipyridamole-induced hyperaemia. Representative examples of the m-mode of the left
ventricle at the level of the papillary muscle (A). Contractile function, as represented by the fractional shortening, measured in rats fed a control
diet (CD) and high fat diet (HFD) for 4 weeks during baseline and dipyridamole-induced hyperaemia (B). Data are expressed as mean± SEM,
n = 6-8. (paired) student t-test, * p< 0.05 diet effect, # p< 0.05 hyperaemia effect.
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http://www.cardiab.com/content/11/1/74diet feeding resulted in development of glucose intoler-
ance, but rats did not become obese. Consequently, obes-
ity can not be explanatory for the findings of the effect of
high fat diet feeding on myocardial function.
Myocardial blood flow reserve is the increase in blood
flow that can be achieved from basal perfusion to maximal
vasodilatation, and is therefore a measurement of the abil-
ity of the microvasculature to respond to an increase in
oxygen demand. In type 1 diabetic rats [8] and patients [9]CD HFD
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Figure 5 Myocardial perfusion measured with contrast echocardiogra
flow reserve (D) in rats fed a control (CD) or high fat diet (HFD) measured
expressed as mean± SEM, n = 4-8. (paired) student t-test, # p< 0.05.it was shown that myocardial blood flow reserve measured
with contrast echocardiography was decreased compared
to healthy controls. In the present study, myocardial blood
flow reserve was unchanged between healthy rats and rats
with glucose intolerance, suggesting that glucose intoler-
ance does not reduce the vasodilating capacity of the myo-
cardium. Increases in myocardial contractile function will
lead to a metabolically-mediated increase in myocardial
blood flow, however, an increase in coronary perfusionHFD
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http://www.cardiab.com/content/11/1/74does not have to increase myocardial contractile function
[5], which might explain the hyperaemic-induced differ-
ences in myocardial function and perfusion in rats with
glucose intolerance.
A limitation of this study is the small amount of rats
used. Although this is a pilot study, ideally, this data set
should have been analysed with a two-way ANOVA with
Bonferronni post-hoc testing for multiple group
comparisons.
Conclusions
In conclusion, the present data demonstrate that diet-
induced glucose intolerance is associated with impaired
myocardial function during conditions of hyperaemia,
but not myocardial perfusion. These findings may result
in new insights into the effect of glucose intolerance on
myocardial function and perfusion during hyperaemia.
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